miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1

JOURNAL ARTICLE published March 2019 in Cancer Gene Therapy

Research funded by National Natural Science Foundation of China (National Science Foundation of China) (81502561)

Authors: Dawei Wu | Jun Zhang | Ying Lu | Song Bo | Lianhong Li | Lu Wang | Qingqing Zhang | Jun Mao